NCT06216535View on ClinicalTrials.gov

Escitalopram in Asthma Patients With Frequent Exacerbation

PHASE2RecruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 19, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

June 1, 2029

Conditions
Asthma
Interventions
DRUG

Escitalopram

Escitalopram is an FDA-approved SSRI antidepressant that is administered by mouth

DRUG

Placebo

Inactive placebo comparator

Trial Locations (1)

75247

RECRUITING

UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Texas Southwestern Medical Center

OTHER